Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CzechiaBack to Czechia

Clinical trials in Plzen – page 4

187 clinical trials in Plzen, Czechia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Plzen at a glance
187
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

187 trials in Plzen

Open in trial search

Major depression

Recruiting

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
  • Sponsor:Neurocrine Biosciences Inc.

Major depression

Recruiting

Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Deupsilocin besilate
  • Sponsor:Cybin IRL Limited

Dermatitis atopic

Recruiting

Study of GHZ339 for treatment of moderate to severe atopic dermatitis

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:GHZ339
  • Sponsor:Novartis Pharma AG

Major depression

Recruiting

Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Deupsilocin besilate
  • Sponsor:Cybin IRL Limited

Acute myeloid leukaemia

Recruiting

Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Janssen Cilag International

Primary biliary cholangitis

Recruiting

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Seladelpar
  • Sponsor:Gilead Sciences Inc.

Cardiac failure chronic+1

Recruiting

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Major depression

Recruiting

Study on the Effectiveness and Safety of NBI-1065845 for Adults with Major Depressive Disorder

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
  • Sponsor:Neurocrine Biosciences Inc.

Study on Vitamin D3 (Colecalciferol) Supplementation in Young Adults and Seniors to Compare Effects and Develop Age-Specific Models

Recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Colecalciferol
  • Sponsor:Fakultni Nemocnice Plzen

Major depression

Recruiting

Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:(1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
  • Sponsor:Vanda Pharmaceuticals Netherlands B.V.

Dementia Alzheimer's type

Recruiting

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Chronic obstructive pulmonary disease

Recruiting

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Plzen

What the registry says about research in the country

01 Hematologic Disorders

Groundbreaking research focusing on blood cancers and related conditions, including studies on innovative treatments for acute myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma. These trials are evaluating new therapeutic combinations and personalized treatment approaches.

  • Leukemia Treatment Studies
  • Multiple Myeloma Research
  • Myelodysplastic Syndrome Investigations
02 Respiratory Medicine

Clinical investigations targeting respiratory conditions, with particular emphasis on treatments for chronic obstructive pulmonary disease, asthma, and chronic rhinosinusitis. Research focuses on evaluating novel therapeutics and their effectiveness in managing symptoms.

  • COPD Management
  • Asthma Control Studies
  • Nasal Polyps Treatment
03 Mental Health

Innovative research addressing psychiatric disorders, including studies on generalized anxiety disorder and major depressive disorder. These trials are evaluating new therapeutic approaches and combination treatments to improve patient outcomes.

  • Anxiety Treatment Studies
  • Depression Management
  • Combination Therapy Research
Back to CzechiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.